The Northwestern Chapter of the
Pennsylvania Society of Health-System Pharmacists
along with the Nesbitt School Of Pharmacy at Wilkes University
Will sponsor a Continuing Education Seminar entitled:
2015 Fall CE Day
Date:
Saturday October 3, 2015
7:00 am - 2:30 pm
Place:
Zem Zem Shrine Club
2525 West 38th Street, Erie, PA 16506
Speakers:
Justine Russell, PharmD, BCPS
Emergency Department Pharmcist, St. Vincent Hospital
Bojana Stevich-Heemer, MS, PharmD, MEd, BCOP
Associate Professor, LECOM School of Pharmacy
Clinical Pharmacy Specialist – Hematology/Oncology, Erie VA Medical Center
Graham Garcia, PharmD
PGY1 Pharmacy Practice Resident, Millcreek Community Hospital
Jessica Anderson, PharmD, Geetika Gandhi, PharmD, Emily Supenia, PharmD,
PGY1 Pharmacy Practice Residents, St. Vincent Hospital
Nancy Chen, PharmD, Seth McCleary, PharmD, Susan Miller, PharmD
PGY1 Pharmacy Practice Residents, UPMC Hamot
Erica Pascale, PharmD, BCPS
Assistant Professor, LECOM School of Pharmacy
Esther Baah, Alyssa Curtis, Brian Kies
PharmD Candidates, Class of 2016, LECOM School of Pharmacy
Fees:
Full PSHP members: No fee
Non-members: $35
Pharmacy students: $20
Fee includes continental breakfast, lunch, and attendance to the CE program. Payment is expected on
the day of the program. No refunds will be given and payment is expected from anyone who does not
attend without providing a 48-hour notice of cancellation.
Registration: Email Rachael Ours, PharmD no later than Friday, September 25, 2014 at nwpshp@gmail.com.
Registration cannot be accepted after this date.
Objectives for Pharmacists:
 Discuss the role of the pharmacist in emergency medicine
 Review various tools and educational opportunities available to develop clinical pharmacy services in the emergency
department
 Explain the implementation and documentation of pharmacy services in the emergency department
 Identify challenges related to practicing in the emergency department setting
 Define specific conditions associated with polycystic ovarian syndrome (PCOS) and mechanisms that exacerbate the
condition
 Outline the non-pharmacological and pharmacological treatment options recommended by the task force for PCOS
 Describe metformin’s role in the treatment of PCOS
 Identify patients that would benefit from glucagon-like peptide (GLP)-1 agonist therapy
 Discuss provisions in the transparency bills and the implications behind them in terms of benefiting patient care and the
overall healthcare system
 Recall the complications of chronic kidney disease
 Distinguish ferric citrate from other phosphate binders
 Recognize appropriate dosing and instructions for use with ferric citrate
 Describe the niche for ketamine use in continuous sedation of ICU patients
 Define the field of pharmacogenomics
 Assess influence of analytical validity, clinical validity, and clinical utility data on clinical pharmacogenetics
 Know the importance of defining evidence for clinical implementation of pharmacogenomics
 Review existing pharmacogenomics clinical practice guideline resources
 Validate benefits of applying pharmacogenetic principles to patient care
 Describe the mechanisms behind the three neurobiologic systems associated with self-mutilation
 Explain why naltrexone is being investigated as a treatment option and where its place will be in therapy
 Name the microorganisms affected by oritavancin when treating acute skin and skin structure infections
 Recognize the specific precautions of oritavancin when used in acute skin and skin structure
 Describe the role of normal saline for volume replacement
 Discuss the implications that new naloxone regulations will have on the opioid abuse problem in Pennsylvania
 Describe the new prescribing authority allowing pharmacists in California and Oregon to prescribe birth control
Objectives for Pharmacy Technicians:
 List two organizations that support pharmacy services in the emergency department
 Name two responsibilities that pharmacy technicians can have in the emergency department
 Define a “best possible medication history” (BPMH)
 Understand the importance of accurate medication reconciliation
 List the recommended treatments for infertility
 Describe metformin’s role in the treatment of Polycystic Ovarian Syndrome (PCOS)
 List five brand name glucagon-like peptide (GLP)-1 agonists.
 Analyze arguments made by drug companies to focus on “value” instead of cost for highly priced medications
 Identify patient populations who may benefit from treatment with ferric citrate
 Identify an indication of ketamine in a critically ill population
 Define the field of pharmacogenomics
 Know the importance of pharmacogenomics for dosing of specific medications
 List clinical practice guideline resources for pharmacogenomics
 Know the benefits of applying pharmacogenetic principles to patient care
 Be able to differentiate between self-injury and suicide
 Describe the current treatment guidelines for self-injury behaviors
 List disease states that oritavancin can be used for
 Recognize the similarities and differences between oritavancin and vancomycin
 Name two products that are used for volume replacement
 Outline the new regulations that will take place in Pennsylvania under Act 139
 Discuss how pharmacy workflow will be impacted by new pharmacist prescribing regulations in California and Oregon
Handouts:
In order to conserve resources, we will not be printing copies of the handouts for all attendees. An email
with the link to the handouts will be sent a week prior to the program to those who have registered. If
you would like a copy of the handouts, please download and print them prior to the meeting.
Alternatively, you may email nwpshp@gmail.com to request a copy of the handouts to be brought to the
meeting for you. Thank you for your understanding.
Information: This is a knowledge based program intended for pharmacists, pharmacy technicians, and pharmacy
students. The seminars presented by NWPSHP are developed to reflect the needs of our members.
These needs are reviewed and assessed annually. Pharmacists, pharmacy technicians, and pharmacy
students with an interest in learning about clinical updates in pharmacy practice should consider
attending this meeting.
Successful completion requires evaluation of the entire session. The evaluation form must be
completed and returned at the conclusion of the program. Partial credit will not be given for late
arrivals or early departures.
This educational session was planned by Stephen Henderson, PharmD and the other officers of
NWPSHP. The planners and faculty for this program have nothing to disclose. Financial support, in the
form of exhibitor fees, has been solicited for this program and will be fully disclosed prior to the
program.
The Nesbitt School of Pharmacy at Wilkes University is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
This program, ACPE #0097-9999-15-056-L01-PT, is approved for 0.5 CEU (5 contact
hours).
The Northwestern Chapter of the
Pennsylvania Society of Health-System Pharmacists
2015 Fall CE Day
Schedule of Events
7:00-7:45
Registration, Continental Breakfast & Exhibits
7:45-8:00
Welcome and Upcoming NWPSHP Events
8:00-9:00
Establishing a Pharmacy Practice in the Emergency Department
Justine Russell, PharmD, BCPS
9:00-9:10
Break & Exhibits
9:10-9:35
Metformin’s Role in the Treatment of Polycystic Ovarian Syndrome
Esther Baah, PharmD Candidate
9:35-10:35
Roundtable Discussions
The Role of GLP-1 Agonists in Diabetes Therapy
Jessica Anderson, PharmD
Money Talks, Should Big Pharma Do the Same?
Nancy Chen, PharmD
The role of ferric citrate (Auryxia) in chronic kidney disease
Graham Garcia, PharmD
Ketamine: Re-emergence of this versatile drug in the management of continuous sedation of
critically ill patients
Emily Supenia, PharmD
10:35-10:45
Break & Exhibits
10:45-11:45
Pharmacogenomics
Bojana Stevich-Heemer, MS, PharmD, MEd, BCOP
11:45-12:45
Lunch & Exhibits
12:45- 1:10
The Use of Naltrexone in Self-mutilation
Alyssa Curtis, PharmD Candidate
1:10-1:35
Oritavancin and its use in Acute Skin and Skin Structure Infections
Brian Kies, PharmD Candidate
1:35-2:20
Roundtable Discussions
Normal Saline: The Ideal Solution for Volume Replacement?
Geetika Gandhi, PharmD
Increased Access to Naloxone: What does this mean for Pennsylvanians?
Seth McCleary, PharmD
Expanding the Scope of the Pharmacist
Susan Miller, PharmD
2:20-2:30
Closing Remarks